clavulanic acid has been researched along with nitrocefin in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.53) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 10 (52.63) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Bush, K; Kania, M; Page, MG; Queenan, AM; Shang, W | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Bethel, CR; Bonomo, RA; Distler, AM; Kasuboski, C; Papp-Wallace, KM; Taracila, M | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Anderson, VE; Bethel, CR; Bonomo, RA; Buynak, JD; Chen, SG; Doppalapudi, VR; Drawz, SM; Hujer, AM; Pagadala, SR; Sheri, A; Skalweit, MJ | 1 |
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M | 1 |
Bethel, CR; Bonomo, RA; Caselli, E; Drawz, SM; Dwulit-Smith, JR; Papp-Wallace, KM; Prati, F; Rodkey, EA; Romagnoli, C; Smith, KM; Taracila, MA; van den Akker, F; Winkler, ML; Xu, Y | 1 |
Jimenez-Valera, M; Ramos-Cormenzana, A; Ruiz-Bravo, A | 1 |
Auger, F; Lacroix, JM; Lamothe, F | 1 |
Chen, HY; Livermore, DM; Yuan, M | 1 |
Bush, K; Lee, VJ; Macalintal, C; Rasmussen, BA; Yang, Y | 1 |
Arora, S; Bal, M | 1 |
Dai, X; Gao, Q; Li, J; Xiang, S; Yang, K | 1 |
Conklin, BC; Hutton, RA; Li, M; Skalweit, MJ; Taracila, MA | 1 |
Arthur, M; Ourghanlian, C; Soroka, D | 1 |
Bell, DT; Chauhan, V; Kaushik, A; Kumar, P; Lamichhane, G; Stevens, RL; Xia, F | 1 |
Sharma, AK; Vats, P | 1 |
Ahmadvand, P; Avillan, JJ; Call, DR; Kang, C; Lewis, JA | 1 |
19 other study(ies) available for clavulanic acid and nitrocefin
Article | Year |
---|---|
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Hydrolysis; Kinetics; Microbial Sensitivity Tests; Spectrophotometry, Ultraviolet | 2007 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tazobactam | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Penicillin sulfone inhibitors of class D beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Catalytic Domain; Cephaloridine; Cephalosporins; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Oxacillin; Penicillins; Recombinant Proteins; Substrate Specificity; Sulfones | 2010 |
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam | 2010 |
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Circular Dichroism; Clavulanic Acid; Crystallography, X-Ray; Drug Design; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds | 2013 |
Synergistic effects of dicloxacillin or clavulanic acid in combination with penicillin G or cephalothin against Yersinia enterocolitica.
Topics: beta-Lactamase Inhibitors; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Dicloxacillin; Drug Synergism; Microbial Sensitivity Tests; Penicillin G; Yersinia enterocolitica | 1986 |
Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Indicators and Reagents; Microbial Sensitivity Tests | 1984 |
Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cloxacillin; Enzyme Inhibitors; Humans; Indicators and Reagents; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa | 1995 |
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Isoelectric Focusing; Kinetics; Molecular Weight; Penicillanic Acid; Spectrophotometry, Ultraviolet; Tazobactam | 1993 |
AmpC beta-lactamase producing bacterial isolates from Kolkata hospital.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Induction; Hospitals; Humans; India; Isoelectric Focusing; Microbial Sensitivity Tests; Species Specificity | 2005 |
Development of a colorimetric assay for rapid quantitative measurement of clavulanic acid in microbial samples.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Clavulanic Acid; Colorimetry; Culture Media, Conditioned; Mutation; Reproducibility of Results; Streptomyces | 2012 |
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Thienamycins | 2012 |
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N
Topics: Amino Acid Motifs; Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Clavulanic Acid; Cloning, Molecular; Drug Combinations; Escherichia coli; Gene Expression; Kinetics; Mutation; Recombinant Proteins; Reverse Genetics; Substrate Specificity | 2017 |
Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; Cephalosporins; Clavulanic Acid; DNA, Intergenic; Gene Expression; Genetic Loci; Humans; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Protein Binding; Thienamycins; Tuberculosis, Multidrug-Resistant | 2017 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Characterization of Interactions between CTX-M-15 and Clavulanic Acid, Desfuroylceftiofur, Ceftiofur, Ampicillin, and Nitrocefin.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Microbial Sensitivity Tests; Molecular Docking Simulation | 2022 |